Furthermore, recent evidence indicates that macrophage‐specific knockout or inhibition of GPR132 enhances glucose homeostasis,[52] indicating that GPR132 may be a critical target for metabolic diseases. This evidence concerns the gene GPR132 and metabolic disease.